DNTH Institutional Ownership

Dianthus Therapeutics, Inc. /DE/

Latest close $110.07 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 28, 2026

Public consensus preview Accumulation leaning 67/100 institutional research score

1 tracked institution Latest filing Jul 28, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$17.77 52-week high$98.70

Latest close $110.07 100.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

BlackRock Jul 28, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 4 parsed filing(s) · 1 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
BlackRock CIK0002012383	Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment	Reported accumulation	3.5M +870.2K	12.00% 0.00 pts	$97.48	$101.61	$110.07
BlackRock CIK0002012383	Mar 31, 2026 observed Apr 27, 2026 filed · 27d Initial Schedule 13G	Initial Schedule 13G	2.6M +989.2K	12.00% +6.40 pts	$83.92	$87.16	$110.07
BlackRock CIK0002012383	Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence	Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal.	1.6M				$110.07

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

GPRE GREEN PLAINS INC 67/100 Accumulation leaning RGEN REPLIGEN CORP 67/100 Accumulation leaning NRIM NORTHRIM BANCORP INC 67/100 Accumulation leaning REAL REALREAL INC/THE 67/100 Accumulation leaning

Recent multi-institution accumulation

TVTX TRAVERE THERAPEUTICS INC 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026